McLeod HL - Search Results

1

Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy.

Ferder NS, Eby CS, Deych E, Harris JK, Ridker PM, Milligan PE, Goldhaber SZ, King CR, Giri T, McLeod HL, Glynn RJ, Gage BF. Ferder NS, et al. Among authors: mcleod hl. J Thromb Haemost. 2010 Jan;8(1):95-100. doi: 10.1111/j.1538-7836.2009.03677.x. Epub 2009 Oct 30. J Thromb Haemost. 2010. PMID: 19874474 Free PMC article. Clinical Trial.

2

Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.

Gage BF, Eby C, Milligan PE, Banet GA, Duncan JR, McLeod HL. Gage BF, et al. Among authors: mcleod hl. Thromb Haemost. 2004 Jan;91(1):87-94. doi: 10.1160/TH03-06-0379. Thromb Haemost. 2004. PMID: 14691573

3

Use of pharmacogenetics to guide warfarin therapy.

Voora D, McLeod HL, Eby C, Gage BF. Voora D, et al. Among authors: mcleod hl. Drugs Today (Barc). 2004 Mar;40(3):247-57. doi: 10.1358/dot.2004.40.3.820088. Drugs Today (Barc). 2004. PMID: 15148533

4

Application of pharmacogenomics in the individualization of chemotherapy for gastrointestinal malignancies.

McLeod HL, King CR, Marsh S. McLeod HL, et al. Clin Colorectal Cancer. 2004 Jun;4 Suppl 1:S43-7. doi: 10.3816/ccc.2004.s.007. Clin Colorectal Cancer. 2004. PMID: 15212705

5

Distribution of ITPA P32T alleles in multiple world populations.

Marsh S, King CR, Ahluwalia R, McLeod HL. Marsh S, et al. Among authors: mcleod hl. J Hum Genet. 2004;49(10):579-581. doi: 10.1007/s10038-004-0183-y. Epub 2004 Aug 21. J Hum Genet. 2004. PMID: 15322947

6

Interethnic variability of ERCC2 polymorphisms.

King CR, Yu J, Freimuth RR, McLeod HL, Marsh S. King CR, et al. Among authors: mcleod hl. Pharmacogenomics J. 2005;5(1):54-9. doi: 10.1038/sj.tpj.6500283. Pharmacogenomics J. 2005. PMID: 15534626

7

Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype.

Voora D, Eby C, Linder MW, Milligan PE, Bukaveckas BL, McLeod HL, Maloney W, Clohisy J, Burnett RS, Grosso L, Gatchel SK, Gage BF. Voora D, et al. Among authors: mcleod hl. Thromb Haemost. 2005 Apr;93(4):700-5. doi: 10.1160/TH04-08-0542. Thromb Haemost. 2005. PMID: 15841315

8

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.

Rieder MJ, Reiner AP, Gage BF, Nickerson DA, Eby CS, McLeod HL, Blough DK, Thummel KE, Veenstra DL, Rettie AE. Rieder MJ, et al. Among authors: mcleod hl. N Engl J Med. 2005 Jun 2;352(22):2285-93. doi: 10.1056/NEJMoa044503. N Engl J Med. 2005. PMID: 15930419 Free article.

9

The pharmacogenetics of coumarin therapy.

Voora D, McLeod HL, Eby C, Gage BF. Voora D, et al. Among authors: mcleod hl. Pharmacogenomics. 2005 Jul;6(5):503-13. doi: 10.2217/14622416.6.5.503. Pharmacogenomics. 2005. PMID: 16014000 Review.

10

Pyrosequencing of clinically relevant polymorphisms.

Marsh S, King CR, Garsa AA, McLeod HL. Marsh S, et al. Among authors: mcleod hl. Methods Mol Biol. 2005;311:97-114. doi: 10.1385/1-59259-957-5:097. Methods Mol Biol. 2005. PMID: 16100402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

588 results

Search Page